Thread by @TRUExDEMON

Something that came to my attention today was the rapid trading of massive blocks on $PROG.

I want to credit u/AwarenessProud1079 for this research, as he has established an interesting link between the original CEO of #PROG and his new affiliations

reddit.com/r/Progenity_PR…

The OP of this post references "Andrew R. Midler" in his post, and states he wasn't able to establish a link between himself and any entities... but I was.

And my findings were... interesting to say the least.

Andrew Midler is associated with Savitr savitrcapital.com

Proof of Midler's association:

insidermonkey.com/hedge-fund/sav…

What makes this interesting isn't just that Andrew Midler appears specifically in Progenity's filings referenced in the redditor's post, but it's the companies Savitr also has an investment in.

Savitr is heavily invested into Progenity to the tune of $217M but also Savitr made a recent heavy investment in a company called "ImmunisAI" which we can see here (source provided by u/AwarenessProud1079)

tracxn.com/d/private-equi…

I found it an EXTRAORDINARY coincidence that Immunis and Progenity are both in the same field of cancer research and early detection, both invested by these large bio-tech and pharmaceutical focused funds.

Upon brief research into this company, I found a familiar face on their board.

Say hello to Dr. Stylli, the former CEO and current Executive Chair of both @Progenity and now Immunis.AI

Not only do I think that u/AwarenessProud1079 is correct in his analysis, I think his findings indicate something much deeper going on with Savitr, Athyrium, and Progenity, owing to the tremendous sum of money it had invested, the large block transactions, & the dramatic SP drop

I believe this sell off was engineered by both of these hedge funds in an effort to accumulate even more shares of Progenity from the market, and they are being frustrated by the lack of "cooperation" from retail because we refuse to sell.

The ATM offering was their last chance.

This accumulation of $PROG shares by these firms suggests that these partnerships are about to make the company extraordinarily valuable, whether that may be in the short or long-term, and these two funds are playing games to build a combined majority holding of more than 70% FF

The sale of $PROG to another firm can be organized by more than one hedge fund, if they cooperate to sell their shares to a large pharmaceutical firm, assuming that is their end-goal.

But given the research Immunis does, there could be more than meets the eye here

Just the news from immunis.ai/news/ alone suggests some significant overlap in these company's research and business focuses.

A partnership, if not an outright merger, may be in the works for these companies, but that is purely speculation.

In any case, there's a very firm link between these companies. They are tied together at the hip, and I'm very certain that Dr. Stylli knows all too well what the investment plan is for all of them.

A buy-out, merger, or beneficial ownership for any or all of these companies...

All of these actions would be bullish in the long run, but how long we would need to wait to see this play out is entirely up in the air.

We don't know how long these firms have been working together, and more research needs to be done.

Regardless of how long it takes, I take these actions and links between these firms as a strong sign of Progenity's future being extremely secure. I'm looking forward to the next set of news releases that come from these companies, but I'll be watching them ALL very closely.

I'll keep digging into all this. Hope everyone did okay in the market today. Bit of a flat day, but consolidation is bullish, and I'm happy to see us stair-stepping back toward $3.

For now, I'll be at work between my job & setting up the discord. Sorry it's taking so long.

Oh, and remember, as always, patience is 🔑